Abeer Shaban is a specialist breast pathologist at QEHB and an Honorary Professor at the University of Birmingham. She has led and contributed to many research trials and book chapters, including the WHO Blue Book for breast tumours. She is a Professional Clinical Advisor for the NHS Breast Screening Programme. She has led a number of research studies and contributed to breast cancer trials as a co-investigator, is a member of a Trial Management Group, and is a central pathology reviewer. She was a member of the NCRI Breast CSG for two terms and acted as Chair of the Translational Subgroup of the NCRI Breast CSG for five years. The subgroup produced several landmark publications, including guidance on improving the turnaround of HER2 testing, the manufacture/reporting of tissue microarrays, and handling neoadjuvant chemotherapy cases. She has published over 110 peer-reviewed papers and contributed to a number of book chapters, including in the WHO Blue Book for Breast Tumours 2019. She co-edited a textbook on molecular pathology: “Molecular pathology for the practising surgical pathologist and cytopathologists”. She led the Cellular and Molecular Pathology initiative (CM-PATH) Workstream 2 (clinical trials). She served as a member of the International Committee of the Royal College of Pathologists and is the Breast Screening Advisor (PCA) for Public Health England in the West Midlands. She organises an annual multidisciplinary breast update course (breastpathologyupdate.com).